Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy

Por Uppada, Srijayaprakash B, Erickson, Terrianne, Wojdyla, Luke, Moravec, David N, Song, Ziyuan, Cheng, Jianjun, Puri, Neelu
Publicado em 2013

T-oligo as an anticancer agent in colorectal cancer

Por Wojdyla, Luke, Stone, Amanda L., Sethakorn, Nan, Uppada, Srijayaprakash B., Devito, Joseph T., Bissonnette, Marc, Puri, Neelu
Publicado no Biochem Biophys Res Commun (2014)

Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer

Por Fong, Jason T., Jacobs, Ryan J., Moravec, David N., Uppada, Srijayaprakash B., Botting, Gregory M., Nlend, Marie, Puri, Neelu
Publicado em 2013

hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang

Por Mulnix, Richard E, Pitman, Ryan T, Retzer, Allison, Bertram, Ceyda, Arasi, Kavin, Crees, Zachary, Girard, Jennifer, Uppada, Srijayaprakash B, Stone, Amanda L, Puri, Neelu
Publicado em 2013

Targeting c-Met in melanoma: Mechanism of resistance and efficacy of novel combinatorial inhibitor therapy

Por Etnyre, Deven, Stone, Amanda L, Fong, Jason T, Jacobs, Ryan J, Uppada, Srijayaprakash B, Botting, Gregory M, Rajanna, Supriya, Moravec, David N, Shambannagari, Manohar R, Crees, Zachary, Girard, Jennifer, Bertram, Ceyda, Puri, Neelu
Publicado em 2014